The emerging treatment of this peptide represents a major development in the care of diabetes mellitus type 2. Different to existing drugs, tirzepatide affects multiple pathways – the GLP-1 hormone and GIP – https://tirzepatide-peptide094700.59bloggers.com/42362970/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment